Table 2.
Depression and anxiety characteristics and management during treatment (after baseline)
| Variable | n (%) |
|---|---|
| Psychiatric diagnosis a | |
| Any psychiatric diagnosis | 96 (37.5) |
| Depression | 53 (20.7) |
| Anxiety | 42 (16.4) |
| Adjustment disorder | 5 (2.0) |
| Bipolar disorder | 4 (1.6) |
| Substance use disorder | 5 (2.0) |
| Other | 10 (3.9) |
| Mental health specialty care a | 43 (18.1) |
| Medications added a | |
| Any medications | 40 (16.8) |
| SSRI | 9 (3.8) |
| SNRI | 10 (4.2) |
| Benzodiazepine | 25 (10.5) |
| Other antidepressant or anxiolytic | 6 (2.5) |
| Baseline medication dose increased during treatment a | 6 (6.5) |
| Patient‐reported symptom—depression b | |
| None | 72 (28.1) |
| Mild | 117 (45.7) |
| Moderate | 56 (21.9) |
| Severe | 7 (2.7) |
| Very severe | 4 (1.6) |
| Patient‐reported symptom—anxiety b | |
| None | 58 (22.7) |
| Mild | 94 (36.7) |
| Moderate | 81 (31.6) |
| Severe | 18 (7.0) |
| Very severe | 5 (2.0) |
| Clinician‐assessed symptom—depression b | |
| None (grade 0) | 133 (56.8) |
| Mild (grade 1) | 72 (30.8) |
| Moderate (grade 2) | 21 (9.0) |
| Severe (grade 3) | 8 (3.4) |
| Clinician‐assessed symptom—anxiety b | |
| None (grade 0) | 61 (26.1) |
| Mild (grade 1) | 125 (53.4) |
| Moderate (grade 2) | 41 (17.5) |
| Severe (grade 3) | 7 (3.0) |
a
Extracted from the electronic medical record.
b
Highest severity at any point during treatment.
Abbreviations: SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.